Citadel Advisors’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
VWA
THC
RC
Citadel Advisors's ULBI Position: Q2 2026 in Review
Citadel Advisors reduced its Ultralife (ULBI) stake by 39% in Q2 2026, selling an estimated $108K and leaving 25,283 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #12293.
Citadel Advisors first reported a position in ULBI in Q1 2014 and has held it in 16 quarters since. The position peaked at $829K in Q3 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.
- Citadel Advisors held 25,283 shares of Ultralife worth $160K as of Q2 2026.
- Citadel Advisors sold 16,018 Ultralife shares in Q2 2026, an estimated $108K.
- Ultralife made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12293 holding.
- Citadel Advisors first reported a position in Ultralife in Q1 2014 and has held it in 16 quarters since.
- Citadel Advisors's Ultralife position peaked at $829K in Q3 2024.
- 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.